Maison Sara Chraïbi Spring 2025 couture runway, fashion show & collection photos. Paris, January 2025.

Russia plans to deliver its first export Su-57E stealth fighter in 2025, likely to Algeria. This move is intensifying regional arms competition with Morocco.

The GHIT Fund awards two-year grant to Fujirebio subsidiary Fluxus to develop an ultrasensitive point-of-care (POC) urine test for tuberculosis (TB).

The substances behind the slimy strings from okra and the gel from fenugreek seeds could trap microplastics better than a commonly used synthetic polymer. Previously, researchers proposed using ...

GHIT Fund has supported arpraziquantel's development journey throughout the overall development program spanning over 10 years.

The GHIT Fund invests in and manages an R&D portfolio of development partnerships aimed at addressing neglected diseases, such as malaria, tuberculosis, and neglected tropical diseases, which ...

TOKYO — H.U. Group Holdings, Inc. and its wholly-owned subsidiary Fujirebio Holdings, Inc. today announced that the Global Health Innovative Technology (GHIT) Fund has awarded a two-year, ...

The aircraft arrived at Oum el Bouaghi Air Base, Oum el Bouaghi Province, on March 13. Algeria is now just the third foreign operator of the Russian Su-35 after China and Iran—while Egypt, India ...

TOKYO, March 18, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.7 billion (USD 11.4 million1) in five projects ...

In addition, GHIT is coordinating, together with the consortium, in-country readiness preparations for introduction of arpraziquantel in additional countries such as Senegal and Tanzania.

TOKYO, March 5, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is today announcing a significant milestone: the first administration of arpraziquantel to preschool-aged ...